Literature DB >> 6745994

IgM-RF prevents complement-mediated inhibition of immune precipitation.

W S Mitchell, J K Naama, J Veitch, K Whaley.   

Abstract

Rheumatoid arthritis (RA) serum inhibits complement-mediated inhibition of immune precipitation (solubilization). We have isolated inhibitory activity from RA sera and shown that it is a property of IgM-rheumatoid factor (IgM-RF) and, to a lesser extent, IgG-RF.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6745994      PMCID： PMC1454486     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  9 in total

1.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

2.  Immunopathologic study of sural nerves in rheumatoid arthritis.

Authors:  D L Conn; F C McDuffie; P J Dyck
Journal:  Arthritis Rheum       Date:  1972 Mar-Apr

3.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

4.  Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Kinetics of labeling and isolation of a labeled peptide.

Authors:  E J Goetzl; H Metzger
Journal:  Biochemistry       Date:  1970-03-03       Impact factor: 3.162

5.  A comparison of the effects of heat-aggregated and chemically cross-linked IgG on monocyte C2 production.

Authors:  K Whaley; D Lappin; A R McPhaden; D W Riches; G P Sandilands
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

6.  Complement fixation by the F(ab')2-fragment of pepsin-treated rabbit antibody.

Authors:  K B Reid
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

7.  Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.

Authors:  J K Naama; W S Mitchell; A Zoma; J Veitch; K Whaley
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

8.  Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.

Authors:  J K Naama; W S Mitchell; K Whaley
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

9.  Inhibition of immune precipitation by complement.

Authors:  J A Schifferli; S R Bartolotti; D K Peters
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330
  9 in total
  15 in total

1.  Measurement of complement activation products in patients with chronic rheumatic diseases.

Authors:  G Auda; E R Holme; J E Davidson; A Zoma; J Veitch; K Whaley
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  Mechanism of action of an inhibitor of complement-mediated prevention of immune precipitation.

Authors:  A E Ahmed; J Veitch; K Whaley
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

3.  Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.

Authors:  J A Schifferli; G Steiger; G Hauptmann; P J Spaeth; A G Sjöholm
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

4.  An inhibitor of complement-mediated prevention of immune precipitation in rheumatoid arthritis--relationship to disease activity and systemic manifestations.

Authors:  W S Mitchell; J Veitch; J Hunter; A Zoma; H Capell; K Whaley
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

5.  Purification of a plasma protein that inhibits complement-mediated prevention of immune precipitation.

Authors:  A E Ahmed; K Whaley
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

6.  Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.

Authors:  I P Niven; K Whaley
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 7.  Antibody-dependent and -independent mechanisms of inflammatory arthritis.

Authors:  Margaret H Chang; Peter A Nigrovic
Journal:  JCI Insight       Date:  2019-03-07

Review 8.  Complement deficiency and immune complex disease.

Authors:  K A Davies; J A Schifferli; M J Walport
Journal:  Springer Semin Immunopathol       Date:  1994

9.  Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.

Authors:  M M O'Sullivan; N Amos; B D Williams
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

10.  Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.

Authors:  G Doekes; J Schouten; A Cats; M R Daha
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.